Evidence map›Paper›PMID 33628167›Full record

ArticleFrontiers in pharmacology2020

The Effects of Gum Acacia on the Composition of the Gut Microbiome and Plasma Levels of Short-Chain Fatty Acids in a Rat Model of Chronic Kidney Disease.

Maha Al-Asmakh, Muhammad Umar Sohail, Ola Al-Jamal, Banan Mosaad Shoair, Asmaa Yousef Al-Baniali, Salma Bouabidi, Shahd Nasr, Hiba Bawadi

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Therapeutic Potential of Gum Arabic (Journal of clinical medicine · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Tongbixiao Pills Improve Gout by Reducing Uric Acid Levels and Inhibiting Inflammation.Dose-response : a publication of International Hormesis Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Maha Al-AsmakhDepartment of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.
Muhammad Umar SohailBiomedical Research Center, QU Health, Qatar University, Doha, Qatar.
Ola Al-JamalBiomedical Research Center, QU Health, Qatar University, Doha, Qatar.
Banan Mosaad ShoairDepartment of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.
Asmaa Yousef Al-BanialiDepartment of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.
Salma BouabidiDepartment of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.
Shahd NasrDepartment of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.
Hiba BawadiHuman Nutrition Department, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.
Qatar University · QA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic kidney disease (CKD) may be fatal for its victims and is an important long-term public health problem. The complicated medical procedures and diet restrictions to which patients with CKD are subjected alter the gut microbiome in an adverse manner, favoring over-accumulation of proteolytic bacteria that produce ammonia and other toxic substances. The present study aimed to investigate the effect of GA on 1) the composition of the gut microbiome and 2) on plasma levels of short-chain fatty acids. Male Wister rats were divided into four groups (six each) and treated for 4 weeks based on the following: control, dietary adenine (0.75%, w/w) to induce CKD, GA in the drinking water (15%, w/v), and both adenine and GA. At the end of the treatment period, plasma, urine, and fecal samples were collected for determination of several biochemical indicators of renal function and plasma levels of short-chain fatty acids (SCFAs) as well as characterization of the gut microbiome. Dietary adenine induced the typical signs of CKD, i.e., loss of body weight and impairment of renal function, while GA alleviated these effects. The intestine of the rats with CKD contained an elevated abundance of pathogenic Proteobacteria, Actinobacteria, and Verrucomicrobia but lowered proportions of

Indexed as

adenineChronic kidney diseasesfirmicutesgum acaciaLactobacillaceaemicrobiomeProteobacteriashort-chain fatty acids

Identifiers

PMID33628167
PMCPMC7898900
OpenAlexW3115960944

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.